July 20, 2026 3-5pm ET
Friday on The Robert Scott Bell Show:
Hour 1
Cycles of Enthusiasm, Reversal, and Revival in Medical Practice Medical practice has long been characterized by cycles of initial enthusiasm for new treatments or procedures, followed by periods of reversal when evidence reveals limitations or harms, and eventual revival or refinement as better understanding emerges, a pattern that underscores the importance of humility, rigorous data collection, and openness to changing course rather than doubling down on flawed approaches. The article examines historical examples including hormone replacement therapy for postmenopausal women, which was widely promoted for heart health and quality of life before large trials showed increased risks of breast cancer, stroke, and blood clots, leading to sharp declines in use and subsequent reevaluation of benefits for specific subgroups. Similar cycles have occurred with routine tonsillectomies, certain cardiac stents, and aggressive blood sugar lowering in diabetes, where initial widespread adoption gave way to more cautious application after randomized trials contradicted earlier observational data. The piece argues that the COVID-19 response exemplified this pattern on a massive scale, with interventions such as lockdowns, broad masking, and certain repurposed drugs initially embraced with high confidence only to face significant reversal as real-world evidence accumulated. It calls for medical leaders and policymakers to recognize these recurring cycles and build systems that encourage early, transparent data sharing, independent verification, and willingness to admit errors rather than defending policies at all costs. The author emphasizes that true scientific progress requires acknowledging uncertainty, learning from reversals, and prioritizing patient outcomes over institutional or narrative consistency. By understanding these patterns, the medical community can reduce harm from premature adoption of interventions and foster a culture of evidence-based humility that ultimately strengthens trust in healthcare.
Why Are Chemicals Being Sprayed Where Our Kids Play and What Can We Do About It? Herbicides and pesticides are routinely sprayed on suburban lawns, school grounds, athletic fields, parks, hospital campuses, and homeowner association-managed green spaces, exposing children to chemical cocktails including 2,4-D, dicamba, MCPA, mecoprop, and quinclorac, despite warning labels that highlight risks to non-target plants, fish, and human health through drift, runoff, and tracking indoors. Amy Sapola notes that these applications, often marketed by companies with reassuring names, create near-daily chemical exposure in neighborhoods as different lawns are treated on staggered schedules, with half-lives measured in days to months meaning residues can persist and overlap with subsequent sprays. Studies have detected lawn-applied 2,4-D in indoor air, house dust, and surfaces, with children showing higher exposure levels, while the National Health and Nutrition Examination Survey found detectable 2,4-D in nearly one-third of participants, with elevated odds in children and women of childbearing age. Short-term symptoms can include eye, skin, and respiratory irritation, while longer-term concerns involve asthma, reproductive effects, and possible cancer links, though causation in real-world mixtures is difficult to prove. The article calls for communities to take action through local ordinances restricting cosmetic pesticide use on public spaces, as seen in New York, Connecticut, Maine, California, and Maryland, and urges parents to report drift or symptoms to poison control and state agencies. Sapola encourages allowing natural biodiversity in lawns, spot-weeding, building soil health, and questioning the necessity of perfect monoculture grass when children should be free to explore, hunt for four-leaf clovers, and interact with living outdoor spaces without chemical flags warning them away. The piece argues that redefining a “healthy lawn” as one alive with clover, violets, and dandelions rather than chemically managed could be part of making America healthy again.
Moderna Injects First Participant With Experimental mRNA-4200 Cancer Shot That Forces the Body to Produce Seven Undisclosed Tumor Proteins Moderna has dosed the first participant in a Phase 1 clinical trial of its experimental mRNA-4200 cancer product, which instructs the body to produce seven undisclosed tumor proteins as part of an “off-the-shelf” therapy intended for multiple solid tumor types including melanoma, lung, esophageal, gastric, ovarian, cervical, endometrial, bladder, and colorectal cancers. The product is being evaluated alone or in combination with pembrolizumab, and unlike personalized mRNA cancer vaccines, it uses shared antigens common across patients and tumor types to induce T-cell responses. The trial is expected to enroll about 42 participants at sites in Michigan, Texas, and Utah. Jon Fleetwood raises safety and informed consent questions about how long the body produces the tumor proteins, where they are expressed, potential off-target effects, and whether the product or its components could be shed through exosomes or extracellular vesicles in bodily fluids, citing studies showing that cells can export proteins via vesicles present in blood, saliva, and other secretions. Moderna has not publicly disclosed the identities of the seven proteins, making independent evaluation difficult. The development continues Moderna’s expansion into mRNA-based cancer therapies, following products that encode immune signaling molecules and pair with checkpoint inhibitors. The article urges contact with Moderna and the FDA for more details on long-term expression, shedding risks, and what trial participants are being told before enrollment.
Sneak Peek Inside the 2026 ESPY Awards Swag Bag for Star Athletes and Celebrities The 2026 ESPY Awards swag bag, distributed to nominees, presenters, and celebrity attendees, features an array of high-end wellness, tech, fashion, and lifestyle products valued at tens of thousands of dollars, reflecting the event’s blend of sports glamour and luxury gifting. Highlights include premium skincare sets from brands emphasizing recovery and anti-aging, high-performance athleisure wear from emerging sustainable lines, noise-canceling headphones and smart recovery devices, artisanal supplements and functional mushroom elixirs marketed for focus and inflammation control, luxury travel accessories, and exclusive experiences such as private training sessions or wellness retreats. Athletes and celebrities also received custom-engraved items, high-end sunglasses, and limited-edition apparel tied to major sports leagues. Organizers partnered with companies targeting the health-conscious, performance-driven demographic of ESPY attendees, incorporating products aligned with current trends in longevity, mental wellness, and biohacking. The bag underscores the intersection of sports, entertainment, and the booming wellness industry, where even non-competitive celebrities receive items designed to appeal to an image-conscious audience. Past years have seen similar lavish collections, but the 2026 edition places heavier emphasis on recovery tech and clean beauty amid growing athlete interest in optimization and longevity. Recipients often share unboxing videos on social media, generating significant brand exposure. The swag bag remains one of the most anticipated non-televised aspects of the ESPYs, blending gratitude for nominees with strategic marketing for participating brands.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
Today’s Homeopathic Hit is Jacaranda caroba, commonly known as Brazilian Caroba-tree.
Boericke notes its reputation in venereal diseases and rheumatism, with important urinary and sexual symptoms, morning sickness, throat irritation, inflamed watery eyes, and rheumatic soreness and stiffness.
Download the Information Sheet
Hour 2
RFK Jr. Wants Fewer Americans on Antidepressants. Here’s Why the Debate Is Exploding. Health and Human Services Secretary Robert F. Kennedy Jr. has called for reducing reliance on antidepressants in the United States, citing concerns over over prescription, limited long-term efficacy for many patients, potential side effects including emotional blunting, sexual dysfunction, withdrawal difficulties, and possible links to increased suicidality in younger populations, sparking intense debate among mental health professionals, patient advocates, and policymakers. Kennedy argues that the sharp rise in antidepressant use has not corresponded with improved mental health outcomes at a population level and that many cases of depression and anxiety could be better addressed through lifestyle interventions, nutrition, exercise, therapy, and addressing root causes such as social isolation, trauma, and environmental factors rather than defaulting to pharmaceutical solutions. Supporters of his position point to studies questioning the serotonin imbalance theory of depression and highlight growing evidence of overdiagnosis and overmedicalization of normal emotional responses, while critics, including many psychiatrists and organizations like the American Psychiatric Association, warn that reducing medication access without robust alternatives could leave vulnerable patients without effective treatment and increase risks of severe depression, hospitalization, or suicide. The debate has intensified as Kennedy’s agency reviews prescribing practices, potential label updates, and deprescribing guidelines, with some experts calling for more research into personalized approaches and others defending antidepressants as lifesaving tools when used appropriately under medical supervision. Public opinion remains divided, with polls showing many Americans concerned about long-term dependence on psychiatric medications amid rising mental health diagnoses, particularly among young adults. The discussion reflects broader tensions in American healthcare between pharmaceutical-centered models and calls for holistic, preventive strategies under the Make America Healthy Again framework.
Special Guest: Barry Smelter
Barry is a Holistic Practitioner who specializes in Environmental Medicine to assist the body in the healing process. He has dedicated his career to healing children and families after his own son was diagnosed with multiple medical conditions, all of which he has significantly improved.
Barry has a Masters in Physician Assistant studies from Finch University/Chicago Medical School and is the first Physician Assistant in the country to become a Fellow of the AAEM. He is an Adjunct Professor at UTHSC in San Antonio and has mentored numerous Physician Assistant students in Environmental Medicine. Barry has done numerous podcasts, interviews and has presented around the world for organizations such as the AAEM, TACA, NIAS, Generation Rescue, and Autism One.
Barry enjoys spending time with his family and friends camping, biking, homesteading, reading and visiting our local farmer’s markets. He and his wife, Linda, have been happily married for the last 27 years. He is the father of six wonderful children. He also enjoys sports, like hockey, football, and golf.
Question of The Day!
Hello RSB & Super Don,
I was just diagnosed with cancer this past weekend (liver and colon) and I am interested in any and all suggestions for supplementation. I was also given a blood transfusion during surgery and was wondering if the herbal ivermectin would be a good option to detox from any mRNA tainted blood that I might have received? Thanks in advance.
Not going down without a fight,
Kim F.
Earth May Have 14 Million Insect Species — More Than Twice What Scientists Thought A new analysis estimates that Earth is home to approximately 14 million insect species, more than double previous scientific estimates of around 6 million, highlighting the vast undiscovered diversity within the most abundant group of animals on the planet and raising important implications for conservation, ecology, and our understanding of global biodiversity. Researchers used advanced statistical modeling, DNA barcoding data, and sampling from understudied regions to extrapolate from known species counts, accounting for the fact that most insects are tiny, short-lived, and inhabit remote or inaccessible habitats where traditional cataloging methods fall short. The updated figure suggests that the majority of insect species remain undescribed, particularly in tropical rainforests, soil ecosystems, and canopy environments that harbor enormous numbers of specialized beetles, flies, wasps, and other groups. The study underscores the critical role insects play in pollination, decomposition, food webs, and nutrient cycling, warning that ongoing habitat loss, pesticide use, and climate change could be driving extinctions of species humans have never even identified. Scientists emphasize the need for accelerated taxonomic efforts, increased funding for biodiversity surveys, and better integration of molecular techniques to map insect diversity before it is lost. The findings also have practical applications for agriculture, medicine, and biotechnology, as many undiscovered insects may hold keys to new pest control methods, pharmaceuticals, or ecosystem services. Overall, the research paints a picture of a far richer and more complex insect world than previously recognized, calling for urgent action to protect these essential but often overlooked creatures that form the foundation of terrestrial ecosystems
Remember Friends, The Power to Heal is Yours!
